Jump to content

Asymmetric hydrogenation

From Wikipedia, the free encyclopedia

Asymmetric hydrogenation is a chemical reaction that adds two atoms of hydrogen to a target (substrate) molecule with three-dimensional spatial selectivity. Critically, this selectivity does not come from the target molecule itself, but from other reagents or catalysts present in the reaction. This allows spatial information (what chemists refer to as chirality) to transfer from one molecule to the target, forming the product as a single enantiomer. The chiral information is most commonly contained in a catalyst and, in this case, the information in a single molecule of catalyst may be transferred to many substrate molecules, amplifying the amount of chiral information present. Similar processes occur in nature, where a chiral molecule like an enzyme can catalyse the introduction of a chiral centre to give a product as a single enantiomer, such as amino acids, that a cell needs to function. By imitating this process, chemists can generate many novel synthetic molecules that interact with biological systems in specific ways, leading to new pharmaceutical agents and agrochemicals. The importance of asymmetric hydrogenation in both academia and industry contributed to two of its pioneers — William Standish Knowles and Ryōji Noyori — being collectively awarded one half of the 2001 Nobel Prize in Chemistry.[1]

History

[edit]

In 1956 a heterogeneous catalyst made of palladium deposited on silk was shown to effect asymmetric hydrogenation.[2] Later, in 1968, the groups of William Knowles and Leopold Horner independently published the examples of asymmetric hydrogenation using a homogeneous catalysts. While exhibiting only modest enantiomeric excesses, these early reactions demonstrated feasibility. By 1972, enantiomeric excess of 90% was achieved, and the first industrial synthesis of the Parkinson's drug L-DOPA commenced using this technology.[3][4]

L-DOPA

The field of asymmetric hydrogenation continued to experience a number of notable advances. Henri Kagan developed DIOP, an easily prepared C2-symmetric diphosphine that gave high ee's in certain reactions. Ryōji Noyori introduced the ruthenium-based catalysts for the asymmetric hydrogenated polar substrates, such as ketones and aldehydes. Robert H. Crabtree demonstrated the ability for Iridium compounds to catalyse asymmetric hydrogenation reactions in 1979 with the invention of Crabtree's catalyst.[5] In the early 1990's, the introduction of P,N ligands by several groups independently then further expanded the scope of the C2-symmetric ligands, although they are not fundamentally superior to chiral ligands lacking rotational symmetry.[6]

Today, asymmetric hydrogenation is a routine methodology in laboratory and industrial scale organic chemistry. The importance of asymmetric hydrogenation was recognized by the 2001 Nobel Prize in Chemistry awarded to William Standish Knowles and Ryōji Noyori.

Mechanism

[edit]

Asymmetric hydrogenations operate by conventional mechanisms invoked for other hydrogenations. This includes inner sphere mechanisms, outer sphere mechanisms and the σ-bond metathesis mechanisms.[7] The type of mechanism employed by a catalyst is largely dependent on the ligands used in a system, which in turn leads to certain catalyst-substrate affinities.

Inner sphere mechanisms

[edit]

The so-called inner sphere mechanism entails coordination of the alkene to the metal center.[8] Other characteristics of this mechanism include a tendency for a homolytic splitting of dihydrogen when more electron-rich, low-valent metals are present while electron-poor, high valent metals normally exhibit a heterolytic cleavage of dihydrogen assisted by a base.[9]

The diagram below depicts purposed mechanisms for catalytic hydrogenation with rhodium complexes which are inner sphere mechanisms. In the unsaturated mechanism, the chiral product formed will have the opposite mode compared to the catalyst used. While the thermodynamically favoured complex between the catalyst and the substrate is unable to undergo hydrogenation, the unstable, unfavoured complex undergoes hydrogenation rapidly.[10] The dihydride mechanism on the other hand sees the complex initially hydrogenated to the dihydride form. This subsequently allows for the coordination of the double bond on the non-hindered side. Through insertion and reductive elimination, the product's chirality matches that of the ligand.[11]

Proposed mechanisms for asymmetric hydrogenation

The preference for producing one enantiomer instead of another in these reactions is often explained in terms of steric interactions between the ligand and the prochiral substrate. Consideration of these interactions has led to the development of quadrant diagrams where "blocked" areas are denoted with a shaded box, while "open" areas are left unfilled. In the modeled reaction, large groups on an incoming olefin will tend to orient to fill the open areas of the diagram, while smaller groups will be directed to the blocked areas and hydrogen delivery will then occur to the back face of the olefin, fixing the stereochemistry. Note that only part of the chiral phosphine ligand is shown for the sake of clarity.

Comparative chemical diagrams
Quadrant model for asymmetric hydrogenation

Outer sphere mechanisms

[edit]

Some catalysts operate by "outer sphere mechanisms" such that the substrate never bonds directly to the metal but rather interacts with its ligands, which is often a metal hydride and a protic hydrogen on a ligand. As such, in most cases dihydrogen is split heterolytically, with the metal acting as a Lewis acid and either an external or internal base "deprotonating" the hydride.[7]

Proposed intermediates in the outer sphere mechanisms for: heterolytic hydrogenation of the catalyst (left) and hydride transfer from the catalyst to the substrate (right)

For an example of this mechanism we can consider the BINAP-Ru-diamine system. The dihalide form of the catalyst is converted to the catalysts by reaction of H2 in the presence of base:[12]

RuCl2(BINAP)(diamine) + 2 KOBu-t + 2 H2 → RuH2(BINAP)(diamine) + 2 KCl + 2 HOBu-t

The resulting catalysts have three kinds of ligands:

  • hydrides, which transfer to the unsaturated substrate
  • diamines, which interact with substrate and with base activator by the second coordination sphere
  • diphosphine, which confers asymmetry.

The "Noyori-class" of catalysts are often referred to as bifunctional catalysts to emphasize the fact that both the metal and the (amine) ligand are functional.[13]

In the hydrogenation of C=O containing substrates, the mechanism was long assumed to operate by a six membered pericyclic transition state/intermediate whereby the hydrido ruthenium hydride center (HRu-NH) interacts with the carbonyl substrate R2C=O.[14] More recent DFT and experimental studies have shown that this model is largely incorrect. Instead, the amine backbone interacts strongly with the base activator, which often is used in large excess.[12] However in both cases, the substrate does not bond directly with the metal centre, thus making it a great example of an outer sphere mechanism.

Metals

[edit]

Practical AH employ platinum metal-based catalysts.[15][16][17]

Base metals

[edit]

Iron is a popular research target for many catalytic processes, owing largely to its low cost and low toxicity relative to other transition metals.[18] Asymmetric hydrogenation methods using iron have been realized, although in terms of rates and selectivity, they are inferior to catalysts based on precious metals.[19] In some cases, structurally ill-defined nanoparticles have proven to be the active species in situ and the modest selectivity observed may result from their uncontrolled geometries.[20]

Ligand classes

[edit]

Phosphine ligands

[edit]

Chiral phosphine ligands, especially C2-symmetric ligands, are the source of chirality in most asymmetric hydrogenation catalysts. Of these the BINAP ligand is well-known, as a result of its Nobel Prize-winning application in the Noyori asymmetric hydrogenation.[3]

Chiral phosphine ligands can be generally classified as mono- or bidentate. They can be further classified according to the location of the stereogenic centre – phosphorus vs the organic substituents. Ligands with a C2 symmetry element have been particularly popular, in part because the presence of such an element reduces the possible binding conformations of a substrate to a metal-ligand complex dramatically (often resulting in exceptional enantioselectivity).[21]

Monodentate phosphines

[edit]

Monophosphine-type ligands were among the first to appear in asymmetric hydrogenation, e.g., the ligand CAMP.[22] Continued research into these types of ligands has explored both P-alkyl and P-heteroatom bonded ligands, with P-heteroatom ligands like the phosphites and phosphoramidites generally achieving more impressive results.[23] Structural classes of ligands that have been successful include those based on the binapthyl structure of MonoPHOS [24] or the spiro ring system of SiPHOS.[25] Notably, these monodentate ligands can be used in combination with each other to achieve a synergistic improvement in enantioselectivity;[26] something that is not possible with the diphosphine ligands.[23]

A chiral monophosphine derived from ferrocene
A ferrocene derivative
The historically important CAMP ligand
The CAMP ligand
A chiral monophosphine derived from BINOL
A BINOL derivative

Chiral diphosphine ligands

[edit]

The diphosphine ligands have received considerably more attention than the monophosphines and, perhaps as a consequence, have a much longer list of achievement. This class includes the first ligand to achieve high selectivity (DIOP), the first ligand to be used in industrial asymmetric synthesis (DIPAMP[27][28][4]) and what is likely the best known chiral ligand (BINAP).[3] Chiral diphosphine ligands are now ubiquitous in asymmetric hydrogenation.

Three chemical diagrams


Historically important diphosphine ligands

P,N and P,O ligands

[edit]
Generic PHOX ligand architecture
Effective ligand for various asymmetric-hydrogenation processes

The use of P,N ligands in asymmetric hydrogenation can be traced to the C2 symmetric bisoxazoline ligand.[29] However, these symmetric ligands were soon superseded by monooxazoline ligands whose lack of C2 symmetry has in no way limits their efficacy in asymmetric catalysis.[30] Such ligands generally consist of an achiral nitrogen-containing heterocycle that is functionalized with a pendant phosphorus-containing arm, although both the exact nature of the heterocycle and the chemical environment phosphorus center has varied widely. No single structure has emerged as consistently effective with a broad range of substrates, although certain privileged structures (like the phosphine-oxazoline or PHOX architecture) have been established.[31][30][32] Moreover, within a narrowly defined substrate class the performance of metallic complexes with chiral P,N ligands can closely approach perfect conversion and selectivity in systems otherwise very difficult to target.[33] Certain complexes derived from chelating P-O ligands have shown promising results in the hydrogenation of α,β-unsaturated ketones and esters.[34]

NHC ligands

[edit]
Chemical diagram
Catalyst developed by Burgess for asymmetric hydrogenation

Simple N-heterocyclic carbene (NHC)-based ligands have proven impractical for asymmetrical hydrogenation.

Some C,N ligands combine an NHC with a chiral oxazoline to give a chelating ligand.[35][36] NHC-based ligands of the first type have been generated as large libraries from the reaction of smaller libraries of individual NHCs and oxazolines.[35][36] NHC-based catalysts featuring a bulky seven-membered metallocycle on iridium have been applied to the catalytic hydrogenation of unfunctionalized olefins[35] and vinyl ether alcohols with conversions and ee's in the high 80s or 90s.[37] The same system has been applied to the synthesis of a number of aldol,[38] vicinal dimethyl[39] and deoxypolyketide[40] motifs, and to the deoxypolyketides themselves.[41]

C2-symmetric NHCs have shown themselves to be highly useful ligands for the asymmetric hydrogenation.[42]

Acyclic substrates

[edit]

Substrates can be classified according to their polarity. Nonpolar substrates are dominated by alkenes. Polar substrates include ketones, enamines ketimines.

Nonpolar substrates

[edit]

[43]

Alkenes that are particularly amenable to asymmetric hydrogenation often feature a polar functional group adjacent to the site to be hydrogenated. In the absence of this functional group, catalysis often results in low ee's. For some unfunctionalized olefins, iridium with P,N-based ligands) have proven effective, however. Alkene substrates are often classified according to their substituents, e.g., 1,1-disubstituted, 1,2-diaryl trisubstituted, 1,1,2-trialkyl and tetrasubstituted olefins.[44][45] and even within these classes variations may exist that make different solutions optimal.[46]

Two chemical diagrams


Example of asymmetric hydrogenation of unfunctionalized olefins


Chiral phosphoramidite and phosphonite ligands used in the asymmetric hydrogenation of enamines

Conversely to the case of olefins, asymmetric hydrogenation of enamines has favoured diphosphine-type ligands; excellent results have been achieved with both iridium- and rhodium-based systems. However, even the best systems often suffer from low ee's and a lack of generality. Certain pyrrolidine-derived enamines of aromatic ketones are amenable to asymmetrically hydrogenation with cationic rhodium(I) phosphonite systems, and I2 and acetic acid system with ee values usually above 90% and potentially as high as 99.9%.[47] A similar system using iridium(I) and a very closely related phosphoramidite ligand is effective for the asymmetric hydrogenation of pyrrolidine-type enamines where the double bond was inside the ring: in other words, of dihydropyrroles.[48] In both cases, the enantioselectivity dropped substantially when the ring size was increased from five to six.

Imines and ketones

[edit]
Noyori catalyst for asymmetric hydrogenation of ketones

Ketones and imines are related functional groups, and effective technologies for the asymmetric hydrogenation of each are also closely related. Early examples are Noyori's ruthenium-chiral diphosphine-diamine system.[49][50]

For carbonyl and imine substrates, end-on, η1 coordination can compete with η2 mode. For η1-bound substrates, the hydrogen-accepting carbon is removed from the catalyst and resists hydrogenation.[51]

Iridium/P,N ligand-based systems have been effective for some ketones and imines. For example, a consistent system for benzylic aryl imines uses the P,N ligand SIPHOX in conjunction with iridium(I) in a cationic complex to achieve asymmetric hydrogenation with ee >90%.[52] An efficient catalyst for ketones, (turnover number (TON) up to 4,550,000 and ee up to 99.9%) is an iridium(I) system with a closely related tridentate ligand.[53]

Two chemical diagrams


Highly effective system for the asymmetric hydrogenation of ketones

The BINAP/diamine-Ru catalyst is effective for the asymmetric reduction of both functionalized and simple ketones,[54] and BINAP/diamine-Ru catalyst can catalyze aromatic, heteroaromatic, and olefinic ketones enantioselectively.[55] Better stereoselectivity is achieved when one substituent is larger than the other (see Flippin-Lodge angle).

BINAP/diamine-Ru catalyst scope
BINAP/diamine-Ru catalyst scope

Aromatic substrates

[edit]

The asymmetric hydrogenation of aromatic (especially heteroaromatic), substrates is a very active field of ongoing research. Catalysts in this field must contend with a number of complicating factors, including the tendency of highly stable aromatic compounds to resist hydrogenation, the potential coordinating (and therefore catalyst-poisoning) abilities of both substrate and product, and the great diversity in substitution patterns that may be present on any one aromatic ring.[56] Of these substrates the most consistent success has been seen with nitrogen-containing heterocycles, where the aromatic ring is often activated either by protonation or by further functionalization of the nitrogen (generally with an electron-withdrawing protecting group). Such strategies are less applicable to oxygen- and sulfur-containing heterocycles, since they are both less basic and less nucleophilic; this additional difficulty may help to explain why few effective methods exist for their asymmetric hydrogenation.

Quinolines, isoquinolines and quinoxalines

[edit]

Two systems exist for the asymmetric hydrogenation of 2-substituted quinolines with isolated yields generally greater than 80% and ee values generally greater than 90%. The first is an iridium(I)/chiral phosphine/I2 system, first reported by Zhou et al..[57] While the first chiral phosphine used in this system was MeOBiPhep, newer iterations have focused on improving the performance of this ligand. To this end, systems use phosphines (or related ligands) with improved air stability,[58] recyclability,[58] ease of preparation,[59] lower catalyst loading[60][61] and the potential role of achiral phosphine additives.[62] As of October 2012 no mechanism appears to have been proposed, although both the necessity of I2 or a halogen surrogate and the possible role of the heteroaromatic N in assisting reactivity have been documented.[56]

The second is an organocatalytic transfer hydrogenation system based on Hantzsch esters and a chiral Brønsted acid. In this case, the authors envision a mechanism where the isoquinoline is alternately protonated in an activating step, then reduced by conjugate addition of hydride from the Hantzsch ester.[63]

Several Chemical Diagrams

Proposed organocatalytic mechanism

Much of the asymmetric hydrogenation chemistry of quinoxalines is closely related to that of the structurally similar quinolines. Effective (and efficient) results can be obtained with an Ir(I)/phophinite/I2 system[64] and a Hantzsh ester-based organocatalytic system,[65] both of which are similar to the systems discussed earlier with regards to quinolines.

Pyridines

[edit]

Pyridines are highly variable substrates for asymmetric reduction (even compared to other heteroaromatics), in that five carbon centers are available for differential substitution on the initial ring. As of October 2012 no method seems to exist that can control all five, although at least one reasonably general method exists.

The most-general method of asymmetric pyridine hydrogenation is actually a heterogeneous method, where asymmetry is generated from a chiral oxazolidinone bound to the C2 position of the pyridine. Hydrogenating such functionalized pyridines over a number of different heterogeneous metal catalysts gave the corresponding piperidine with the substituents at C3, C4, and C5 positions in an all-cis geometry, in high yield and excellent enantioselectivity. The oxazolidinone auxiliary is also conveniently cleaved under the hydrogenation conditions.[66]

Several chemical diagrams


Asymmetric hydrogenation of pyridines with heterogeneous catalyst

Methods designed specifically for 2-substituted pyridine hydrogenation can involve asymmetric systems developed for related substrates like 2-substituted quinolines and quinoxalines. For example, an iridium(I)\chiral phosphine\I2 system is effective in the asymmetric hydrogenation of activated (alkylated) 2-pyridiniums[67] or certain cyclohexanone-fused pyridines.[68] Similarly, chiral Brønsted acid catalysis with a Hantzsh ester as a hydride source is effective for some 2-alkyl pyridines with additional activating substitution.[69]

Indoles and pyrroles

[edit]

The asymmetric hydrogenation of indoles has been established with N-Boc protection.[70]

Diagram of chemical process


Method for asymmetric hydrogenation of Boc-protected indoles

A Pd(TFA)2/H8-BINAP system achieves the enantioselective cis-hydrogenation of 2,3- and 2-substituted indoles.[71][72]

Illustration of chemical process


Sequential alkylation and asymmetric hydrogenation of 2-substituted indoles

Akin to the behavior of indoles, pyrroles can be converted to pyrrolidines by asymmetric hydrogenation.[73]


The asymmetric hydrogenation of 2,3,5-substituted N-Boc pyrroles

Oxygen- and sulfur-containing heterocycles

[edit]

The asymmetric hydrogenation of furans and benzofurans is challenging.[74]


The asymmetric hydrogenation of furans and benzofurans

Asymmetric hydrogenation of thiophenes and benzothiophenes has been catalyzed by some ruthenium(II) complexes of N-heterocyclic carbenes (NHC). This system appears to possess superb selectivity (ee > 90%) and perfect diastereoselectivity (all cis) if the substrate has a fused (or directly bound) phenyl ring but yields only racemic product in all other tested cases.[75]


The asymmetric hydrogenation of thiophenes and benzothiophenes

Heterogeneous catalysis

[edit]

No heterogeneous catalyst has been commercialized for asymmetric hydrogenation.

The first asymmetric hydrogenation focused on palladium deposited on a silk support. Cinchona alkaloids have been used as chiral modifiers for enantioselectivity hydrogenation.[76]

Cinchonidine, one of the cinchona alkaloids

An alternative technique and one that allows more control over the structural and electronic properties of active catalytic sites is the immobilization of catalysts that have been developed for homogeneous catalysis on a heterogeneous support. Covalent bonding of the catalyst to a polymer or other solid support is perhaps most common, although immobilization of the catalyst may also be achieved by adsorption onto a surface, ion exchange, or even physical encapsulation. One drawback of this approach is the potential for the proximity of the support to change the behaviour of the catalyst, lowering the enantioselectivity of the reaction. To avoid this, the catalyst is often bound to the support by a long linker though cases are known where the proximity of the support can actually enhance the performance of the catalyst.[76]

The final approach involves the construction of MOFs that incorporate chiral reaction sites from a number of different components, potentially including chiral and achiral organic ligands, structural metal ions, catalytically active metal ions, and/or preassembled catalytically active organometallic cores.[77] One of these involved ruthenium-based catalysts. As little as 0.005 mol% of such catalysts proved sufficient to achieve the asymmetric hydrogenation of aryl ketones, although the usual conditions featured 0.1 mol % of catalyst and resulted in an enantiomeric excess of 90.6–99.2%.[78]


The active site of a heterogeneous zirconium phosphonate catalyst for asymmetric hydrogenation

Industrial applications

[edit]
(S,S)-Ro 67-8867

Asymmetric hydrogenations are used in the production of several drugs, such as the antibacterial levofloxin, the antibiotic carbapenem, and the antipsychotic agent BMS181100.[15][16][17]

Noyori asymmetric hydrogenation
Noyori asymmetric hydrogenation

Knowles' research into asymmetric hydrogenation and its application to the production scale synthesis of L-Dopa[4] gave asymmetric hydrogenation a strong start in the industrial world. A 2001 review indicated that asymmetric hydrogenation accounted for 50% of production scale, 90% of pilot scale, and 74% of bench scale catalytic, enantioselective processes in industry, with the caveat that asymmetric catalytic methods in general were not yet widely used.[79]

Asymmetric hydrogenation has replaced kinetic resolution based methods has resulted in substantial improvements in the process's efficiency.[12] can be seen in a number of specific cases where the For example, Roche's Catalysis Group was able to achieve the synthesis of (S,S)-Ro 67-8867 in 53% overall yield, a dramatic increase above the 3.5% that was achieved in the resolution based synthesis.[80] Roche's synthesis of mibefradil was likewise improved by replacing resolution with asymmetric hydrogenation, reducing the step count by three and increasing the yield of a key intermediate to 80% from the original 70%.[81]


Asymmetric hydrogenation in the industrial synthesis of mibefradil

Noyori-inspired hydrogenation catalysts have been applied to the commercial synthesis of number of fine chemicals. (R)-1,2-Propandiol, precursor to the antibacterial levofloxacin, can be efficiently synthesized from hydroxyacetone using Noyori asymmetric hydrogenation:[17]

levofloxaxin synthesis
levofloxaxin synthesis

Newer routes focus on the hydrogenation of (R)-methyl lactate.[12]

An antibiotic carbapenem is also prepared using Noyori asymmetric hydrogenation via (2S,3R)-methyl 2-(benzamidomethyl)-3-hydroxybutanoate, which is synthesized from racemic methyl 2-(benzamidomethyl)-3-oxobutanoate by dynamic kinetic resolution.

carbapenem synthesis
carbapenem synthesis

An antipsychotic agent BMS 181100 is synthesized using BINAP/diamine-Ru catalyst.

BMS181110 synthesis
BMS181110 synthesis

References

[edit]
  1. ^ "The Nobel Prize in Chemistry 2001". 2001-10-10.
  2. ^ Akabori, S.; Sakurai, S.; Izumi, Y.; Fujii, Y. (1956). "An Asymmetric Catalyst". Nature. 178 (4528): 323. Bibcode:1956Natur.178..323A. doi:10.1038/178323b0. PMID 13358737. S2CID 4221816.
  3. ^ a b c Noyori, R. (2003). "Asymmetric Catalysis: Science and Opportunities (Nobel Lecture 2001)". Advanced Synthesis & Catalysis. 345 (12): 15–41. doi:10.1002/adsc.200390002.
  4. ^ a b c Knowles, W. S. (2002). "Asymmetric Hydrogenations (Nobel Lecture)". Angewandte Chemie International Edition. 41 (12): 1998–2007. doi:10.1002/1521-3773(20020617)41:12<1998::AID-ANIE1998>3.0.CO;2-8. PMID 19746594.
  5. ^ Crabtree, Robert (1979). "Iridium compounds in catalysis". Accounts of Chemical Research. 12 (9): 331–337. doi:10.1021/ar50141a005.
  6. ^ Pfaltz, A. (2004). "Asymmetric Catalysis Special Feature Part II: Design of chiral ligands for asymmetric catalysis: From C2-symmetric P,P- and N,N-ligands to sterically and electronically nonsymmetrical P,N-ligands". Proceedings of the National Academy of Sciences. 101 (16): 5723–5726. Bibcode:2004PNAS..101.5723P. doi:10.1073/pnas.0307152101. PMC 395974. PMID 15069193.
  7. ^ a b de Vries, Johannes G.; Elsevier, Cornelis J., eds. (2006-10-20). The Handbook of Homogeneous Hydrogenation (1 ed.). Wiley. doi:10.1002/9783527619382. ISBN 978-3-527-31161-3.
  8. ^ Gridnev, I. D.; Imamoto, T. (2004). "On the Mechanism of Stereoselection in Rh-Catalyzed Asymmetric Hydrogenation: A General Approach for Predicting the Sense of Enantioselectivity". Accounts of Chemical Research. 37 (9): 633–644. doi:10.1021/ar030156e. PMID 15379579.
  9. ^ Wen, Jialin; Wang, Fangyuan; Zhang, Xumu (2021). "Asymmetric hydrogenation catalyzed by first-row transition metal complexes". Chemical Society Reviews. 50 (5): 3211–3237. doi:10.1039/D0CS00082E. ISSN 0306-0012. PMID 33480901.
  10. ^ Gridnev, Ilya D.; Imamoto, Tsuneo (2004-09-01). "On the Mechanism of Stereoselection in Rh-Catalyzed Asymmetric Hydrogenation: A General Approach for Predicting the Sense of Enantioselectivity". Accounts of Chemical Research. 37 (9): 633–644. doi:10.1021/ar030156e. ISSN 0001-4842.
  11. ^ Imamoto, Tsuneo; Tamura, Ken; Zhang, Zhenfeng; Horiuchi, Yumi; Sugiya, Masashi; Yoshida, Kazuhiro; Yanagisawa, Akira; Gridnev, Ilya D. (2012-01-25). "Rigid P-Chiral Phosphine Ligands with tert -Butylmethylphosphino Groups for Rhodium-Catalyzed Asymmetric Hydrogenation of Functionalized Alkenes". Journal of the American Chemical Society. 134 (3): 1754–1769. doi:10.1021/ja209700j. ISSN 0002-7863. PMID 22192064.
  12. ^ a b c d Dub, Pavel A.; Gordon, John C. (2018). "The role of the metal-bound N–H functionality in Noyori-type molecular catalysts". Nature Reviews Chemistry. 2 (12): 396–408. doi:10.1038/s41570-018-0049-z. S2CID 106394152.
  13. ^ Noyori, Ryōji; Masashi Yamakawa; Shohei Hashiguchi (2001-11-01). "Metal−Ligand Bifunctional Catalysis: A Nonclassical Mechanism for Asymmetric Hydrogen Transfer between Alcohols and Carbonyl Compounds". The Journal of Organic Chemistry. 66 (24): 7931–7944. doi:10.1021/jo010721w. PMID 11722188.
  14. ^ Ohkuma, T.; Ooka, H.; Ikariya, T.; Noyori, R. (1995), "Preferential hydrogenation of aldehydes and ketones", Journal of the American Chemical Society, 117 (41): 10417–10418, doi:10.1021/ja00146a041
  15. ^ a b Ikariya, T.; Blacker, A. J. (2007). "Asymmetric Transfer Hydrogenation of Ketones with Bifunctional Transition Metal-Based Molecular Catalysts". Accounts of Chemical Research. 40 (12): 1300–1308. doi:10.1021/ar700134q. PMID 17960897.
  16. ^ a b Pilkington, C.; Lennon, I. (2003). "The Application of Asymmetric Hydrogenation for the Manufacture of Pharmaceutical Intermediates:The Need for Catalyst Diversity". Synthesis. 2003 (11): 1639. doi:10.1055/s-2003-40871.
  17. ^ a b c Noyori, R. (2002), "Asymmetric Catalysis: Science and Opportunities (Nobel Lecture)", Angewandte Chemie International Edition, 41 (12): 2008–22, doi:10.1002/1521-3773(20020617)41:12<2008::aid-anie2008>3.0.co;2-4, PMID 19746595
  18. ^ Enthaler, S.; Junge, K.; Beller, M. (2008). "Sustainable Metal Catalysis with Iron: From Rust to a Rising Star?". Angewandte Chemie International Edition. 47 (18): 3317–21. doi:10.1002/anie.200800012. PMID 18412184.
  19. ^ Mikhailine, A.; Lough, A. J.; Morris, R. H. (2009). "Efficient Asymmetric Transfer Hydrogenation of Ketones Catalyzed by an Iron Complex Containing a P−N−N−P Tetradentate Ligand Formed by Template Synthesis". Journal of the American Chemical Society. 131 (4): 1394–1395. doi:10.1021/ja809493h. PMID 19133772.
  20. ^ Sonnenberg, J. F.; Coombs, N.; Dube, P. A.; Morris, R. H. (2012). "Iron Nanoparticles Catalyzing the Asymmetric Transfer Hydrogenation of Ketones". Journal of the American Chemical Society. 134 (13): 5893–5899. doi:10.1021/ja211658t. PMID 22448656.
  21. ^ Whitesell, J. K. (1989). "C2 symmetry and asymmetric induction". Chemical Reviews. 89 (7): 1581–1590. doi:10.1021/cr00097a012.
  22. ^ Knowles, W. S.; Sabacky, M. J.; Vineyard, B. D. (1972). "Catalytic asymmetric hydrogenation". Journal of the Chemical Society, Chemical Communications. 214 (1): 119–124. doi:10.1039/C39720000010. PMID 4270504.
  23. ^ a b Jerphagnon, T.; Renaud, J. L.; Bruneau, C. (2004). "Chiral monodentate phosphorus ligands for rhodium-catalyzed asymmetric hydrogenation". Tetrahedron: Asymmetry. 15 (14): 2101. doi:10.1016/j.tetasy.2004.04.037.
  24. ^ Van Den Berg, M.; Minnaard, A. J.; Schudde, E. P.; Van Esch, J.; De Vries, A. H. M.; De Vries, J. G.; Feringa, B. L. (2000). "Highly Enantioselective Rhodium-Catalyzed Hydrogenation with Monodentate Ligands" (PDF). Journal of the American Chemical Society. 122 (46): 11539. doi:10.1021/ja002507f. hdl:11370/3c92d080-f024-45fe-b997-b100634bd612. S2CID 95403641.
  25. ^ Fu, Y.; Xie, J. H.; Hu, A. G.; Zhou, H.; Wang, L. X.; Zhou, Q. L. (2002). "Novel monodentate spiro phosphorus ligands for rhodium-catalyzed hydrogenation reactions". Chemical Communications (5): 480–481. doi:10.1039/B109827F. PMID 12120551.
  26. ^ Reetz, M. T.; Sell, T.; Meiswinkel, A.; Mehler, G. (2003). "A New Principle in Combinatorial Asymmetric Transition-Metal Catalysis: Mixtures of Chiral Monodentate P Ligands". Angewandte Chemie International Edition. 42 (7): 790–3. doi:10.1002/anie.200390209. PMID 12596201.
  27. ^ Vineyard, B. D.; Knowles, W. S.; Sabacky, M. J.; Bachman, G. L.; Weinkauff, D. J. (1977). "Asymmetric hydrogenation. Rhodium chiral bisphosphine catalyst". Journal of the American Chemical Society. 99 (18): 5946. doi:10.1021/ja00460a018.
  28. ^ Knowles, W. S.; Sabacky, M. J.; Vineyard, B. D.; Weinkauff, D. J. (1975). "Asymmetric hydrogenation with a complex of rhodium and a chiral bisphosphine". Journal of the American Chemical Society. 97 (9): 2567. doi:10.1021/ja00842a058.
  29. ^ Müller, D.; Umbricht, G.; Weber, B.; Pfaltz, A. (1991). "C2-Symmetric 4,4',5,5'-Tetrahydrobi(oxazoles) and 4,4',5,5'-Tetrahydro-2,2'-methylenebis[oxazoles] as Chiral Ligands for Enantioselective Catalysis Preliminary Communication". Helvetica Chimica Acta. 74: 232–240. doi:10.1002/hlca.19910740123.
  30. ^ a b Helmchen, G. N.; Pfaltz, A. (2000). "PhosphinooxazolinesA New Class of Versatile, Modular P,N-Ligands for Asymmetric Catalysis". Accounts of Chemical Research. 33 (6): 336–345. doi:10.1021/ar9900865. PMID 10891051.
  31. ^ Lightfoot, A.; Schnider, P.; Pfaltz, A. (1998). "Enantioselective Hydrogenation of Olefins with Iridium-Phosphanodihydrooxazole Catalysts". Angewandte Chemie International Edition. 37 (20): 2897–2899. doi:10.1002/(SICI)1521-3773(19981102)37:20<2897::AID-ANIE2897>3.0.CO;2-8. PMID 29711115.
  32. ^ Franzke, A.; Pfaltz, A. (2011). "Zwitterionic Iridium Complexes with P,N-Ligands as Catalysts for the Asymmetric Hydrogenation of Alkenes". Chemistry: A European Journal. 17 (15): 4131–44. doi:10.1002/chem.201003314. PMID 21381140.
  33. ^ Maurer, F.; Huch, V.; Ullrich, A.; Kazmaier, U. (2012). "Development of Catalysts for the Stereoselective Hydrogenation of α,β-Unsaturated Ketones". The Journal of Organic Chemistry. 77 (11): 5139–5143. doi:10.1021/jo300246c. PMID 22571628.
  34. ^ Rageot, D.; Woodmansee, D. H.; Pugin, B. T.; Pfaltz, A. (2011). "Proline-Based P,O Ligand/Iridium Complexes as Highly Selective Catalysts: Asymmetric Hydrogenation of Trisubstituted Alkenes". Angewandte Chemie International Edition. 50 (41): 9598–601. doi:10.1002/anie.201104105. PMID 21882320.
  35. ^ a b c Perry, M. C.; Cui, X.; Powell, M. T.; Hou, D. R.; Reibenspies, J. H.; Burgess, K. (2003). "Optically Active Iridium Imidazol-2-ylidene-oxazoline Complexes: Preparation and Use in Asymmetric Hydrogenation of Arylalkenes". Journal of the American Chemical Society. 125 (1): 113–123. doi:10.1021/ja028142b. PMID 12515512.
  36. ^ a b Nanchen, S.; Pfaltz, A. (2006). "Synthesis and Application of Chiral N-Heterocyclic Carbene–Oxazoline Ligands: Iridium-Catalyzed Enantioselective Hydrogenation". Chemistry: A European Journal. 12 (17): 4550–8. doi:10.1002/chem.200501500. PMID 16557626.
  37. ^ Zhu, Y.; Burgess, K. (2008). "Iridium-Catalyzed Asymmetric Hydrogenation of Vinyl Ethers". Advanced Synthesis & Catalysis. 350 (7–8): 979. doi:10.1002/adsc.200700546.
  38. ^ Zhao, J.; Burgess, K. (2009). "Aldol-Type Chirons from Asymmetric Hydrogenations of Trisubstituted Alkenes". Organic Letters. 11 (10): 2053–2056. doi:10.1021/ol900308w. PMID 19368378.
  39. ^ Zhao, J.; Burgess, K. (2009). "Synthesis of Vicinal Dimethyl Chirons by Asymmetric Hydrogenation of Trisubstituted Alkenes". Journal of the American Chemical Society. 131 (37): 13236–13237. doi:10.1021/ja905458n. PMID 19719102.
  40. ^ Zhou, J.; Burgess, K. (2007). "Α,ω-Functionalized 2,4-Dimethylpentane Dyads and 2,4,6-Trimethylheptane Triads through Asymmetric Hydrogenation". Angewandte Chemie International Edition. 46 (7): 1129–31. doi:10.1002/anie.200603635. PMID 17200966.
  41. ^ Zhou, J.; Zhu, Y.; Burgess, K. (2007). "Synthesis of (S,R,R,S,R,S)-4,6,8,10,16,18- Hexamethyldocosane from Antitrogus parvulus via Diastereoselective Hydrogenations". Organic Letters. 9 (7): 1391–1393. doi:10.1021/ol070298z. PMID 17338543.
  42. ^ Urban, S.; Ortega, N.; Glorius, F. (2011). "Ligand-Controlled Highly Regioselective and Asymmetric Hydrogenation of Quinoxalines Catalyzed by Ruthenium N-Heterocyclic Carbene Complexes". Angewandte Chemie International Edition. 50 (16): 3803–6. doi:10.1002/anie.201100008. PMID 21442699.
  43. ^ Cui, X.; Burgess, K. (2005). "Catalytic Homogeneous Asymmetric Hydrogenations of Largely Unfunctionalized Alkenes". Chemical Reviews. 105 (9): 3272–3296. doi:10.1021/cr0500131. PMID 16159153.
  44. ^ Pàmies, O.; Andersson, P. G.; Diéguez, M. (2010). "Asymmetric Hydrogenation of Minimally Functionalised Terminal Olefins: An Alternative Sustainable and Direct Strategy for Preparing Enantioenriched Hydrocarbons". Chemistry: A European Journal. 16 (48): 14232–40. doi:10.1002/chem.201001909. PMID 21140401.
  45. ^ Woodmansee, D. H.; Pfaltz, A. (2011). "Asymmetric hydrogenation of alkenes lacking coordinating groups". Chemical Communications. 47 (28): 7912–7916. doi:10.1039/c1cc11430a. PMID 21556431.
  46. ^ Mazuela, J.; Verendel, J. J.; Coll, M.; SchäFfner, B. N.; BöRner, A.; Andersson, P. G.; PàMies, O.; DiéGuez, M. (2009). "Iridium Phosphite−Oxazoline Catalysts for the Highly Enantioselective Hydrogenation of Terminal Alkenes". Journal of the American Chemical Society. 131 (34): 12344–12353. doi:10.1021/ja904152r. PMID 19658416.
  47. ^ Hou, G. H.; Xie, J. H.; Wang, L. X.; Zhou, Q. L. (2006). "Highly Efficient Rh(I)-Catalyzed Asymmetric Hydrogenation of Enamines Using Monodente Spiro Phosphonite Ligands". Journal of the American Chemical Society. 128 (36): 11774–11775. doi:10.1021/ja0644778. PMID 16953614.
  48. ^ Hou, G. H.; Xie, J. H.; Yan, P. C.; Zhou, Q. L. (2009). "Iridium-Catalyzed Asymmetric Hydrogenation of Cyclic Enamines". Journal of the American Chemical Society. 131 (4): 1366–1367. doi:10.1021/ja808358r. PMID 19132836.
  49. ^ Noyori, R.; Ohkuma, T. (2001). "Asymmetric Catalysis by Architectural and Functional Molecular Engineering: Practical Chemo- and Stereoselective Hydrogenation of Ketones". Angewandte Chemie International Edition. 40 (1): 40–73. doi:10.1002/1521-3773(20010105)40:1<40::AID-ANIE40>3.0.CO;2-5. PMID 11169691.
  50. ^ Hems, W. P.; Groarke, M.; Zanotti-Gerosa, A.; Grasa, G. A. (2007). "[(Bisphosphine) Ru(II) Diamine] Complexes in Asymmetric Hydrogenation: Expanding the Scope of the Diamine Ligand". Accounts of Chemical Research. 40 (12): 1340–1347. doi:10.1021/ar7000233. PMID 17576143.
  51. ^ Noyori, R.; Yamakawa, M.; Hashiguchi, S. (2001). "Metal−Ligand Bifunctional Catalysis: A Nonclassical Mechanism for Asymmetric Hydrogen Transfer between Alcohols and Carbonyl Compounds". The Journal of Organic Chemistry. 66 (24): 7931–7944. doi:10.1021/jo010721w. PMID 11722188.
  52. ^ Zhu, S. F.; Xie, J. B.; Zhang, Y. Z.; Li, S.; Zhou, Q. L. (2006). "Well-Defined Chiral Spiro Iridium/Phosphine−Oxazoline Cationic Complexes for Highly Enantioselective Hydrogenation of Imines at Ambient Pressure". Journal of the American Chemical Society. 128 (39): 12886–12891. doi:10.1021/ja063444p. PMID 17002383.
  53. ^ Xie, J. H.; Liu, X. Y.; Xie, J. B.; Wang, L. X.; Zhou, Q. L. (2011). "An Additional Coordination Group Leads to Extremely Efficient Chiral Iridium Catalysts for Asymmetric Hydrogenation of Ketones". Angewandte Chemie International Edition. 50 (32): 7329–32. doi:10.1002/anie.201102710. PMID 21751315.
  54. ^ Ohkuma, T.; Ooka, H.; Yamakawa, M.; Ikariya, T.; Noyori, R. (1996), "Stereoselective Hydrogenation of Simple Ketones Catalyzed by Ruthenium(II) Complexes", The Journal of Organic Chemistry, 61 (15): 4872–4873, doi:10.1021/jo960997h
  55. ^ Noyori, R.; Ohkuma, T. (2001), "Asymmetric Catalysis by Architectural and Functional Molecular Engineering: Practical Chemo- and Stereoselective Hydrogenation of Ketones", Angewandte Chemie International Edition, 40 (1): 40–73, doi:10.1002/1521-3773(20010105)40:1<40::aid-anie40>3.0.co;2-5, PMID 11169691
  56. ^ a b Zhou, Y. G. (2007). "Asymmetric Hydrogenation of Heteroaromatic Compounds". Accounts of Chemical Research. 40 (12): 1357–1366. CiteSeerX 10.1.1.653.5495. doi:10.1021/ar700094b. PMID 17896823.
  57. ^ Wang, W. B.; Lu, S. M.; Yang, P. Y.; Han, X. W.; Zhou, Y. G. (2003). "Highly Enantioselective Iridium-Catalyzed Hydrogenation of Heteroaromatic Compounds, Quinolines". Journal of the American Chemical Society. 125 (35): 10536–10537. CiteSeerX 10.1.1.651.3119. doi:10.1021/ja0353762. PMID 12940733.
  58. ^ a b Xu, L.; Lam, K. H.; Ji, J.; Wu, J.; Fan, Q. H.; Lo, W. H.; Chan, A. S. C. (2005). "Air-stable Ir-(P-Phos) complex for highly enantioselective hydrogenation of quinolines and their immobilization in poly(ethylene glycol) dimethyl ether (DMPEG)". Chemical Communications (11): 1390–2. doi:10.1039/B416397D. hdl:10397/8906. PMID 15756313.
  59. ^ Lam, K. H.; Xu, L.; Feng, L.; Fan, Q. H.; Lam, F. L.; Lo, W. H.; Chan, A. S. C. (2005). "Highly Enantioselective Iridium-Catalyzed Hydrogenation of Quinoline Derivatives Using Chiral Phosphinite H8-BINAPO". Advanced Synthesis & Catalysis. 347 (14): 1755. doi:10.1002/adsc.200505130. hdl:10397/26878.
  60. ^ Wang, Z. J.; Deng, G. J.; Li, Y.; He, Y. M.; Tang, W. J.; Fan, Q. H. (2007). "Enantioselective Hydrogenation of Quinolines Catalyzed by Ir(BINAP)-Cored Dendrimers: Dramatic Enhancement of Catalytic Activity". Organic Letters. 9 (7): 1243–1246. doi:10.1021/ol0631410. PMID 17328554.
  61. ^ Qiu, L.; Kwong, F. Y.; Wu, J.; Lam, W. H.; Chan, S.; Yu, W. Y.; Li, Y. M.; Guo, R.; Zhou, Z.; Chan, A. S. C. (2006). "A New Class of Versatile Chiral-Bridged Atropisomeric Diphosphine Ligands: Remarkably Efficient Ligand Syntheses and Their Applications in Highly Enantioselective Hydrogenation Reactions". Journal of the American Chemical Society. 128 (17): 5955–5965. doi:10.1021/ja0602694. hdl:10397/60397. PMID 16637664.
  62. ^ Reetz, M. T.; Li, X. (2006). "Asymmetric hydrogenation of quinolines catalyzed by iridium complexes of BINOL-derived diphosphonites". Chemical Communications (20): 2159–60. doi:10.1039/b602320g. PMID 16703140.
  63. ^ Rueping; Antonchick, A.; Theissmann, T. (2006). "A highly enantioselective Brønsted acid catalyzed cascade reaction: organocatalytic transfer hydrogenation of quinolines and their application in the synthesis of alkaloids". Angewandte Chemie International Edition in English. 45 (22): 3683–3686. doi:10.1002/anie.200600191. PMID 16639754.
  64. ^ Tang, W.; Xu, L.; Fan, Q. H.; Wang, J.; Fan, B.; Zhou, Z.; Lam, K. H.; Chan, A. S. C. (2009). "Asymmetric Hydrogenation of Quinoxalines with Diphosphinite Ligands: A Practical Synthesis of Enantioenriched, Substituted Tetrahydroquinoxalines". Angewandte Chemie International Edition. 48 (48): 9135–8. doi:10.1002/anie.200904518. hdl:10397/20432. PMID 19876991.
  65. ^ Rueping, M.; Tato, F.; Schoepke, F. R. (2010). "The First General, Efficient and Highly Enantioselective Reduction of Quinoxalines and Quinoxalinones". Chemistry: A European Journal. 16 (9): 2688–91. doi:10.1002/chem.200902907. PMID 20140920.
  66. ^ Glorius, F.; Spielkamp, N.; Holle, S.; Goddard, R.; Lehmann, C. W. (2004). "Efficient Asymmetric Hydrogenation of Pyridines". Angewandte Chemie International Edition. 43 (21): 2850–2. doi:10.1002/anie.200453942. PMID 15150766.
  67. ^ Ye, Z. S.; Chen, M. W.; Chen, Q. A.; Shi, L.; Duan, Y.; Zhou, Y. G. (2012). "Iridium-Catalyzed Asymmetric Hydrogenation of Pyridinium Salts". Angewandte Chemie International Edition. 51 (40): 10181–4. doi:10.1002/anie.201205187. PMID 22969060.
  68. ^ Tang, W. J.; Tan, J.; Xu, L. J.; Lam, K. H.; Fan, Q. H.; Chan, A. S. C. (2010). "Highly Enantioselective Hydrogenation of Quinoline and Pyridine Derivatives with Iridium-(P-Phos) Catalyst". Advanced Synthesis & Catalysis. 352 (6): 1055. doi:10.1002/adsc.200900870. hdl:10397/22884.
  69. ^ Rueping, M.; Antonchick, A. P. (2007). "Organocatalytic Enantioselective Reduction of Pyridines". Angewandte Chemie International Edition. 46 (24): 4562–5. doi:10.1002/anie.200701158. PMID 17492817.
  70. ^ Baeza, A.; Pfaltz, A. (2010). "Iridium-Catalyzed Asymmetric Hydrogenation of N-Protected Indoles". Chemistry: A European Journal. 16 (7): 2036–9. doi:10.1002/chem.200903105. PMID 20104554.
  71. ^ Xiao, Y. C.; Wang, C.; Yao, Y.; Sun, J.; Chen, Y. C. (2011). "Direct Asymmetric Hydrosilylation of Indoles: Combined Lewis Base and Brønsted Acid Activation". Angewandte Chemie International Edition. 50 (45): 10661–4. doi:10.1002/anie.201105341. PMID 21932274.
  72. ^ Duan, Y.; Chen, M. W.; Ye, Z. S.; Wang, D. S.; Chen, Q. A.; Zhou, Y. G. (2011). "An Enantioselective Approach to 2,3-Disubstituted Indolines through Consecutive Brønsted Acid/Pd-Complex-Promoted Tandem Reactions". Chemistry: A European Journal. 17 (26): 7193–7. doi:10.1002/chem.201100576. PMID 21567504.
  73. ^ Wang, D. S.; Ye, Z. S.; Chen, Q. A.; Zhou, Y. G.; Yu, C. B.; Fan, H. J.; Duan, Y. (2011). "Highly Enantioselective Partial Hydrogenation of Simple Pyrroles: A Facile Access to Chiral 1-Pyrrolines". Journal of the American Chemical Society. 133 (23): 8866–8869. doi:10.1021/ja203190t. PMID 21591641.
  74. ^ Wang, D. S.; Chen, Q. A.; Lu, S. M.; Zhou, Y. G. (2012). "Asymmetric Hydrogenation of Heteroarenes and Arenes". Chemical Reviews. 112 (4): 2557–2590. doi:10.1021/cr200328h. PMID 22098109.
  75. ^ Urban, S.; Beiring, B.; Ortega, N.; Paul, D.; Glorius, F. (2012). "Asymmetric Hydrogenation of Thiophenes and Benzothiophenes". Journal of the American Chemical Society. 134 (37): 15241–15244. doi:10.1021/ja306622y. PMID 22934527.
  76. ^ a b Heitbaum, M.; Glorius, F.; Escher, I. (2006). "Asymmetric Heterogeneous Catalysis". Angewandte Chemie International Edition. 45 (29): 4732–62. doi:10.1002/anie.200504212. PMID 16802397.
  77. ^ Yoon, M.; Srirambalaji, R.; Kim, K. (2012). "Homochiral Metal–Organic Frameworks for Asymmetric Heterogeneous Catalysis". Chemical Reviews. 112 (2): 1196–1231. doi:10.1021/cr2003147. PMID 22084838.
  78. ^ Hu, A.; Ngo, H. L.; Lin, W. (2003). "Chiral Porous Hybrid Solids for Practical Heterogeneous Asymmetric Hydrogenation of Aromatic Ketones". Journal of the American Chemical Society. 125 (38): 11490–11491. doi:10.1021/ja0348344. PMID 13129339.
  79. ^ Blaser, H. U.; Spindler, F.; Studer, M. (2001). "Enantioselective catalysis in fine chemicals production". Applied Catalysis A: General. 221 (1–2): 119–143. doi:10.1016/S0926-860X(01)00801-8. PMID 12613584.
  80. ^ Blaser, Hans-Ulrich; Federsel, Hans-Jürgen, eds. (2010). Asymmetric Catalysis on Industrial Scale. Weinheim: Wiley-VCH. pp. 13–16. doi:10.1002/9783527630639. ISBN 978-3-527-63063-9.
  81. ^ Jacobsen, E.N.; Pfaltz, Andreas; Yamamato, H., eds. (1999). Comprehensive Asymmetric Catalysis. Berlin; New York: Springer. pp. 1443–1445. ISBN 978-3-540-64336-4.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Asymmetric_hydrogenation&oldid=1241468140"